I. Introduction
As a near-room temperature ionized gas, cold atmospheric plasma (CAP) has demonstrated its promising capability in cancer treatment by causing the selective death of cancer cells in vitro [1]–[3]. The CAP treatment on several subcutaneous xenograft tumors and melanoma in mice has also demonstrated its potential clinical application [4]–[7]. The rise of intracellular reactive oxygen species (ROS), DNA damage, mitochondrial damage, as well as apoptosis have been extensively observed in the CAP-treated cancer cell lines [8]–[10]. The increase of intracellular ROS may be due to the complicated intracellular pathways or the diffusion of extracellular ROS through the cellular membrane [11]. However, the exact underlying mechanism is still far from clear.